1.     BURG G   (1975): Erkrankungen des Retikulohistiocytären Systems (RHS) der Haut. Enzymcytochemische und immuncytologische Untersuchungen mit besonderer Berücksichtigung der Zelldifferenzierung; Habilitationsschrift, München

2.     HUHN D, BURG G, MEMPEL W (1973): Spezifische Hautveränderungen bei Morbus Hodgkin; Dtsch med Wschr 52: 2469-2472

3.     BURG G, BRAUN-FALCO O (1974) :Qualitative und quantitative Aspekte der cellulären Reaktion in Haut und Blut bei Mycosis fungoides; Hautarzt 25: 178-187

4.     BURG G, BRAUN-FALCO O (1975) : T- und B- Lymphocyten in Hautveränderungen kutaner Lymphome. Ein Beitrag zur Klassifikation lymphoretikulärer Proliferationen in der Haut; Dtsch med Wschr 100: 2562-256

5.     BURG G, BRAUN-FALCO O (1975): Classification and Differentiation of Cutaneous Lymphomas.  Enzyme-cytochemical and immunocytological studies; Br J Dermatol 93: 597-599

6.     BRAUN-FALCO O, BURG G (1975) : Lymphoretikuläre Proliferationen in der Haut. Cytochemische und immunocytologische Unter­suchungen bei Lymphadenosis benigna cutis; Hautarzt 26: 124-132

7.     WEBER K, BURG G, WOLFF HH, BRAUN-FALCO O, EHLERS G (1975): Sézary-Syndrom. Ein Bericht anhand eines Falles; Hautarzt 26: 255-259

8.     BURG G, BRAUN-FALCO O (1977) : Enzymzytochemische und immunzytologische Untersuchungen bei Mycosis fungoides; Acta histochemica Suppl. Bd. XVIII: 209-214

9.     HOFMANN C, BURG G, PLEWIG G, BRAUN-FALCO O (1977): Photochemotherapie kutaner Lymphome. Orale und lokale 8-MOP-UVA-Therapie; Dtsch med Wschr 102: 675-679

10.   v.LIEBE V, BURG G (1977) : Lymphozytentransformationstest bei kutanen Lymphomen; Hautarzt 28, Suppl. II: 200-203

11.   SCHMOECKEL CH, BRAUN-FALCO O, BURG G (1977) : Zur Ultrastruktur der Mycosis fungoides und des Sézary Syndroms; Hautarzt 28, Suppl. II: 197-198

12.   SCHMOECKEL C, BURG G, WOLFF HH, BRAUN-FALCO O (1977): The ultrastructure of lymphadenosis benigna cutis (pseudolymphoma cutis); Arch Derm-Res 258: 161-167

13.   BURG G, BRAUN-FALCO O, HOFFMANN-FEZER G, RODT H, SCHMOECKEL C (1978) : Patterns of cutaneous lymphomas. Histological, Enzyme Cytochemical, and Immunological Typing of Lymphorecticular Proliferations in the Skin; Dermatologica 157: 282-291

14.   BURG G, BRAUN-FALCO O, SCHMOECKEL C, HOFFMANN-FEZER G,FATEH-MOGHADAM A, HERTERICH J (1978): Preferential microenvironments for B- and T- lymphocytes in the skin; Inserm 80: 221-238

15.   BURG G, RODT H, GROSSE-WILDE H, BRAUN-FALCO O (1978): Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sézary's syndrome; J Invest Derm 70: 257-259

16.   BURG G, SCHMOECKEL C, BRAUN-FALCO O, WOLFF HH (1978): Monocytic Leukemia. Clinically Appearing as "Malignant Reticulosis of the Skin"; Arch Derm 114: 418-420

17.   BRAUN-FALCO O, GUGGENBERGER K, BURG G, FATEH-MOGHADAM A (1978): Immunozytom unter dem Bild einer Acrodermatitis chronica atrophicans; Hautarzt 29: 644-647

18.   SCHMOECKEL C, BRAUN-FALCO O, BURG G (1978): Die pagetoide Retikulose - ein T-Zell Lymphom?; Hautarzt 29, Suppl. III: 57-60

19.   KERL H, BURG G (1979) : Immunozytome und immunoblastische Lymphome der Haut; Hautarzt 30: 666-672

20.   KIENITZ T, BURG G, SCHMOECKEL C, WEITZ H, BRAUN-FALCO O (1979): High-grade malignant lymphoma arising from Sézary's syndrome; Dermatologica 158: 126-136

21.   SCHMOECKEL C, BURG G, BRAUN-FALCO O (1979): Quantitative analysis of lymphoid cells in mycosis fungoides, Sézary's syndrome and para­psoriasis en plaques; Arch Dermatol Res 264: 17-28

22.   SCHMOECKEL C, BURG G, BRAUN-FALCO O (1979): Quantitiative analysis of lymphoid cells in cutaneous low-grade malignant B-cell lymphomas; Arch Dermatol Res 266: 239-251

23.   BURG G, GUGGENBERGER K, SCHMOECKEL C, BRAUN-FALCO O (1980): Therapie der Mycosis fungoides; Therapie der Gegenwart 119: 773-790

24.   SCHMOECKEL C, BURG G, BRAUN-FALCO O, KLINGMÜLLER G (1981): Mycosis fongoide à forte malignité avec transformation cytologique ; Ann Dermatol Venereol (Paris) 108: 231-241

25.   BURG G, HOFFMANN-FEZER G, NIKOLOWSKI J, SCHMOECKEL C, BRAUN-FALCO O, STÜNKEL L (1981): Lymphomatoid papulosis: A cutaneous T-cell pseudolymphoma; Acta Dermatovener (Stockholm) 61: 491-496

26.   SCHMOECKEL C, BURG G, HOFFMANN-FEZER G, STOLZ W, WEITZ H, LÖHRS U, BRAUN-FALCO O (1982) : Cutaneous Immunoblastic T-cell lymphoma; SArch Dermatol Res 274: 141-154

27.   STOLZ W, SCHMOECKEL CH, BURG G, BRAUN-FALCO O (1983): Circulating Sézary cells in the diagnosis of Sézary Syndrome (quantitative and morphometric analysis);  J Invest Derm 81:314-319

28.   PRZYBILLA B, BURG G, SCHMOECKEL CH, BRAUN-FALCO O (1983): Treatment of cutaneous T-cell lymphomas with TP-5; Acta Derm Venereol 63:524-529

29.   EBERTH-WILLERSHAUSEN W, STEGER O, BARRAN W, BURG G, RYCKMANNS F, KAUDEWITZ P (1984): Histiozytosis X. Eine oligosymptomatische Form des M. Hand-Schüller-Christian mit einer neuen Form und Möglichkeit der Diagnostik; Hautarzt 35:539-542

30.   GEERTS ML, BURG G, SCHMOECKEL CH, BRAUN-FALCO O (1984): Alkaline phosphatase positive lymphoma; Dermatologica 169:342-347

31.   KAUDEWITZ P, BURG G, STEIN H, KLEPZIG K, MASON DY, BRAUN-FALCO O (1985) : Monoclonal antibody patterns in lymphomatoid papulosis; Dermatologic Clinics 3:749-757

32.   MAIER H, SCHMOECKEL CH, BURG G, BRAUN-FALCO O (1985) : Primary cutaneous atypical histiocytosis with possible dissemination; Am J Dermatopathol 7:373-382

33.   SMOLLE J, KAUDEWITZ P, BURG G, KRESBACH H, KERL H (1985): Significance of non-lymphoid ("accessory") cells in malignant lymphomas and pseudo-lymphomas of the skin; Br J Dermatol 111:677-685

34.   IMAI S, BURG G, BRAUN-FALCO O (1986): Mycosis fungoides and Sézary syndrome show distinct histomorphological features; Dermatologica 173:131-135

35.   KAUDEWITZ P, STEIN H, BURG G, MASON DY, BRAUN-FALCO O (1986):Atypical cells in lymphomatoid papulosis express the Hodgkin cell-associated antigen Ki-1; J Invest Dermatol 86:350-354

36.   BURG G, KLEPZIG K, KAUDEWITZ K, WOLF H, BRAUN-FALCO O (1986): Acyclovir in lymphomatoid papulosis and mycosis fungoides; JAMA 256:214-215

37.   BURG G, KLEPZIG K, KAUDEWITZ P, WOLF H, BRAUN-FALCO O (1986) Acyclovir bei Mycosis fungoides und lymphomatoider Papulose; Hautarzt 37:533-536

38.   KAUDEWITZ P, SOLDNER R, BURG G, BIEBER T, BERGER C, EDELSON R, RIEBER P, BRAUN-FALCO O (1986) : Reactivity of monoclonal antibody BE2 in different stages of mycosis fungoides and in benign dermal infiltrates; Arch Dermatol Res 279:83-88

39.   KAUDEWITZ P, BURG G, MACIEJEWSKI G, GERDES J, SCHWARTING R, BRAUN-FALCO O (1987): Cell Populations in Pagetoid Reticulosis: An Immunological Study Using Cell Activation Associated Monoclonal Antibodies; Acta Derm Venereol 67: 24-29

40.   BURG G, STÜNKEL GK, BIEBER T, OPIZ U, KAUDEWITZ P (1987): Cutaneous infiltrates of histiocytosis X contains plasminogen activator-bearing epidermtropic dentritic cells different from Langerhans cells ; Arch Dermatol Res 279: 88- 91

41.   FEIST H, ROHLOFF R, WIESMETH A, WIELLICH N, WENDT TH, BURG G (1987) : Dosimetry and first clinical results of total skin electron beam therapy of cutaneous T cell lymphoma; Strahlentherapie und Onkologie 163: 273-274

42.   VON DER HELM D, VON DER HELM K, BURG G, BRAUN-FALCO O, DEINHARDT F (1988) : Antikörper gegen HTLV I bei T-lymphoproliferativen Erkrankungen der Haut; Hautarzt 39: 348-350

43.   ECKERT F, HEIN R, KRIEG TH, BURG G (1988) : Lokal rezidivierendes zentroblastisches Lymphom der Haut; Hautarzt 39: 791-794

44.   ECKERT F, SCHMID U, KAUDEWITZ P, BURG G, BRAUN-FALCO O (1989): Follicular lymphoid hyperplasia of the skin with high content of Ki-1 positive lymphocytes; Am J Dermatopathol 11: 345-352

45.   KAUDEWITZ P, STEIN H, DALLENBACH F, ECKERT F, BIEBER K, BURG G, BRAUN-FALCO O (1989): Primary and Secondary Cutaneous Ki-1+ (CD30+) Anaplastic Large Cell Lymphomas; Am J Pathol 135: 359-367

46.   STOLZ W, VOGT T, BRAUN-FALCO O, ABMAYR W, ECKERT F, KAUDEWITZ P, VIELUF D, BIEBER K, BURG G (1990): Differentiation Between Lymphomas and Pseudolymphomas of the Skin by Computerized DNA-Image Cytometry; J Invest Dermatol 94: 254-260

47.   KAUDEWITZ P, STEIN H, PLEWIG G, SCHWARTING R, GERDES J, BURG G, KIND P, ECKERT F, BRAUN-FALCO O (1990): Hodgkin's disease followed by lymphomatoid papulosis; J Am Acad Dermatol 22: 999-1006

48.   SEPP N, SCHULER G, ROMANI N, GEISSLER D, GATTRINGER C, BURG G, BARTRAM CR, FRITSCH P (1990): "Intravascular Lymphomatosis" (Angioendotheliosis): Evidence for a T-cell origin in two cases; Hum Pathol 21: 1051-1058

49.   DUMMER R, NESTLE F, WIEDE J, SCHÄFER E, RÖGER J, BECKER J.C, VOGT TH, BURG G (1991): Coincidence of increased soluble interleukin-2 receptors, diminished natural killer cell activity and progressive disease in cutaneous T-cell lymphomas; Eur J Dermatol 1:135-138

50.   VOGT TH, STOLZ W, BRAUN-FALCO O, KAUDEWITZ P, ECKERT F, ABMAYR W, DUMMER R, BURG G (1991): Prognostic Significance of DNA Cytometry in Cutaneous Malignant Lymphomas; Cancer 68:1095-1100

51.   RÖGER J, BURG G, MILLER K, LANZ U (1991): Pityriasis rubra pilaris-artiges Vorstadium eines Sézary-Syndroms; Z Hautkr 66:1046-1050

52.   BURG G, DUMMER R, WILHELM M, NESTLE F, OTT MM, FELLER A, HEFNER H, LANZ U, SCHWINN A, WIEDE J (1991): A Subcutaneous Delta-Positive T-Cell Lymphoma That Produces Interferon Gamma; New Engl J Med 325:1078-1081

53.   DUMMER R, POSSECKERT G, NESTLE F, WITZGALL R, BURGER M, BECKER JC, SCHÄFER E, WIEDE J, SEBALD W, BURG G (1991); Soluble Interleukin-2 Receptors Inhibit Interleukin 2-Dependent Proliferation and Cyto-toxicity: Explanation for Diminished Natural Killer Cell Activity in Cutaneous T-Cell Lymphomas In Vivo?; J Invest Dermatol 98:50-54

54.   WILHELM M, MEYER P, BATRAM C, TONY HP, DUMMER R, NESTLE F, BURG G, WILMS K (1992) : g/dReceptor-expressing T-cell clones from a cutaneous T-cell lymphoma suppress hemato­poiesis*; Ann Hematol 65:111-115

55.   DUMMER R, RÖGER J, VOGT TH, BECKER J, HEFNER H, SINDERMANN H, BURG G (1992): Topical Application of Hexadecylphosphocholine in Patients with Cutaneous Lymphomas ; Prog Exp Tumor Res. Basel, Karger, 34:160-169

56.   DUMMER R, KOHL O, GILLESSEN J, KÄGI M, BURG G (1993): Peripheral Blood Mononuclear Cells in Patients With Nonleukemic Cutaneous T-Cell Lymphoma; Arch Dermatol 129:433-436

57.   DUMMER R, BURG G, NESTLE F, KOHL O (1993): Soluble interleukin-2 receptors and cutaneous T-cell lymphoma (letter); Cancer 71:3793-3795

58.   WILHELM M, MEYER P, BATRAM C, TONY HP, DUMMER R, NESTLE F, BURG G, WILMS K (1992); g/dReceptor-expressing T-cell clones from a cutaneous T-cell lymphoma suppress hemato­poiesis; Ann Hematol 65:111-115

59.   DUMMER R, RÖGER J, VOGT TH, BECKER J, HEFNER H, SINDERMANN H, BURG G (1992); Topical Application of Hexadecylphosphocholine in Patients with Cutaneous Lymphomas ; Prog Exp Tumor Res. Basel, Karger, 34:160-169

60.   DUMMER R, KOHL O, GILLESSEN J, KÄGI M, BURG G (1993); Peripheral Blood Mononuclear; Cells in Patients With Nonleukemic Cutaneous T-Cell Lymphoma; Arch Dermatol 129:433-436

61.   DUMMER R, BURG G, NESTLE F, KOHL O (1993);Soluble interleukin-2 receptors and cutaneous T-cell lymphoma (letter); Cancer 71:3793-3795

62.   DUMMER R, KRASOVEC M, RÖGER J, SINDERMANN H, BURG G (1993); Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: Results of a phase I/II study; J Am Acad Dermatol 29:963-970

63.   DUMMER R, HAEFFNER AC, BURG G (1994); Cutaneous T-cell lymphomas (CTCL): new aspects in PCR-based diagnostic tools, immunology and treatment; Eur J Dermatol 4: 281-286

64.   BURG G, HESS SCHMID M, KÜNG E, DOMMANN ST, DUMMER R (1994); Semimalignant (“pseudolymphomatous”) cutaneous B-cell lymphomas; Dermatologic Clinics 12; 2: 399-407

65.   BURG G, ZWINGERS TH, STAEGEMEIR E, SANTUCCI M (1994); EORTC-Cutaneous Lymphoma Project Group; Interrater and intrarater variabilities in the evaluation of cutaneous lymphoproliferative T-cell infiltrates; Dermatologic Clinics 12:2:311-314

66.   SANTUCCI M, BURG G, FELLER AC (1994); Interrater And Intrarater Reliability Of Histologic Criteria In Early Cutaneous T-Cell Lymphoma; Dermatologic Clinics 12;2:323-327

67.   BURG G, DUMMER R, BECKER JC (1995); The skin as a target organ during IL-2 administration; Basic Mechanisms of Physiologic and Aberrant Lymphoproliferation in the Skin; Edited by W.C. Lambert et al., Plenum Press New York, 1994; S. 451-458

68.   BAUCH B, BARRAUD-KLENOVSEK M, BURG G, DUMMER R (1995); Eindrucksvolle Remission einer Mycosis fungoides im Tumorstadium unter low-dose Interferon-a und Acitretin nach erfolgloser Chemotherapie; H+G 70; 3: 200-202

69.   WYSS M, DUMMER R, DOMMANN SN, JOLLER-JEMELKA HI, DOURS-ZIMMERMANN MT, GILLIET F, BURG G (1995); Lymphomatoid Papulosis - Treatment with recombinant Interferon Alfa-2a and Etretinate; Dermatology 190: 288 – 291

70.   PAULLI M, BERTI E, ROSSO R, BURG G  ET AL (1995); CD30/Ki-1-Positive Lymphoproliferative Disorders of the Skin - Clinicopathologic Correlation and Statistical Analysis of 86 Cases: A Multicentric Study From the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group; J Clin Oncol 13: 1343 – 1354

71.   BÖNI R, DUMMER R, DOMMANN-SCHERRER C, DOMMANN S, ZIMMERMANN DR, JOLLER-JEMELKA H, BURG G (1995): Necrotizing herpes zoster mimicking relapse of vasculitis in angioimmunoblastic lymphadeno­pathy with dysproteinaemie; Br J Dermatology 133: 978 – 982

72.   DOMMANN SN, DOMMANN-SCHERRER CC, ZIMMERMANN D, DOURS-ZIMMER­MANN MT, HASSAM S, BURG G (1995); Primary cutaneous T-cell-rich B-cell lymphoma. A case report with a 13-year follow-up. ; Am J Dermatopathol. 17; 6: 618 – 624

73.   BÖNI R, DAVIS-DANESHFAR A, BURG G, FUCHS D, WOOD GS (1996); No detection of HTLV-I proviral DNA in lesional skin biopsies from Swiss and German patients with cutaneous T-cell lymphoma; Br J Dermatol 134: 282 – 284

74.   DUMMER R, POTOCZNA N, HÄFFNER AC, ZIMMERMANN DR, GILARDI ST, BURG G (1996); A Primary Cutaneous Non-T, Non-B CD4+, CD56+ Lymphoma; Arch Dermatol, 1996; 132: 550-553

75.   BURG G, DUMMER R, NESTLE FO, DOEBBELING U, HÄFFNER A (1996); Cutaneous Lymphomas Consist of a Spectrum of Nosologically Different Entities Including Mycosis Fungoides and Small Plaque Parapsoriasis; Arch Dermatol 132: 567 – 572

76.   KALINKE U, DUMMER R, BURG G (1996); Management of cutaneous T-cell lymphoma; Current Opinion in Dermatology 3: 71 – 76

77.   POTOCZNA N, BOEHNCKE W.-H. , NESTLE FO, KÜENZLEN CH, STERRY W, BURG G, DUMMER R (1996); T-cell receptor ß variable region (Vß) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin; J Cutan Pathol 23: 298 – 305

78.   DOMMANN STNW, DOMMANN-SCHERRER CC, DOURS-ZIMMERMANN M-T, ZIMMERMANN DR, KURAL-SERBES B, BURG G (1996); Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas; Arch Dermatol Res 288: 163-167

79.   RAJAN GP, SEIFERT B, PRÜMMER O, JOLLER-LEMELKA HI, BURG G, DUM­MER R (1996); Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA; Arch Dermatol Res 288: 543-548

80.   DUMMER R, HEALD PW, NESTLE FO, LUDWIG E, LAINE E, HEMMI S, BURG G (1996); Sézary Syndrome T-Cell Clones Display T-Helper 2 Cytokines and Express the Accessory Factor-1 (Interferon-g Receptor ß-Chain); Blood 88 (4): 1383 – 1389

81.   WOOD GS, HARDMAN DL, BÖNI R, DUMMER R, KIM Y-H, SMOLLER BR, TAKESHI­TA M, KIKUCHI M, BURG G (1996); Lack of the t (2;5) or Other Mutations Resulting in Expression of Anaplastic Lymphoma Kinase Catalytic Domain in CD30+ Primary Cutaneous Lymphoproliferative Disorders and Hodgkin’s Disease; Blood (88) 5; 1765 – 1770

82.   DOMMANN SNW, DOMMANN-SCHERRER CC, DOURS-ZIMMERMANN MT, ZIMMERMANN DR, KURAL-SERBES B, BURG G (1996); Cutaneous pleomorphic T-cell lymphoma showing lineage cross-over of antigen receptor gene rearrangement ; Eur J Dermatol 6: 196 – 199

83.   CAMACHO FM, BURG G, MORENO JC, CAMPORA RG, VILLAR JL (1997); Granulomatous Slack Skin in Childhood; Pediatric Dermatology 14 (3): 204 – 208

84.   MEYER JC, HASSAM S, DUMMER R, MULETTA S, DÖBBELING U, DOMMANN SNW, BURG G (1997); A realistic approach to the sensitivity of PCR-DGGE and its application as a sensitive tool for the detection of clonality in cutaneous T-cell proliferations; Exp Dermatol 6: 122 – 127

85.   DOMMANN SNW, DOMMANN-SCHERER CC, ZIEGLER TH, MEYER J, TRÜEB RM, KÜNDIG TH, PANIZZON R, BURG G (1997); Expression of Intercellular Adhesion Molecule 3 (CDw50) on Endithelial Cells in Cutaneous Lymphomas;Am J Dermatopathol 19 (4): 391 – 395

86.   DÖBBELING U, DUMMER R, HESS SCHMID M, BURG G (1997);Lack of expression of the recombination activating genes RAG-1 and RAG-2 in cutaneous T-cell lymphoma: pathogenic implications; Clinical and Experimental Dermatology 22: 230 – 233

87.   DUMMER R, GEERTSEN R, LUDWIG E, NIEDERER E, BURG G (1998); Sézary Syndrome, T-Helper 2 Cytokines and Accessory Factor-1 (AF-1); Leukemia and Lymphoma, 28: 515 – 522

88.   DÖBBELING U, DUMMER R, LAINE E, POTOCZNA N, QIN JZ, BURG G (1998); Interleukin-15 Is an Autocrine/Paracrine Viability Factor for Cutaneous T-cell Lymphoma Cells; Blood 92 (1): 252 – 258

89.   KEMPF W, DUMMER R, MÜLLER B, DÖBBELING U, HÄFFNER A, NESTLE FO, BURG G (1998); Cutaneous Lymphoproliferative Infiltrates-  Entities, Concepts and a New Clinically-Oriented Approach Beyond the Classifications; Korean Journal of Investigative Dermatology; 5 (2): 103 – 120

90.   KAMARASHEV J, BURG G, KEMPF W, HESS SCHMID M, DUMMER R (1998); Comparative analysis of histological and immunohistologal features in mycosis fungoides and Sézary syndrome; J Cutan Pathol 25: 407 – 412

91.   BRÄUNINGER A, HANSMANN M-L, STRICKLER JG, DUMMER R, BURG G, RAJEWS­KY K, KÜPPERS R (1999); Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma; The New England Journal of Medicine 340: 1239 – 1247

92.   DUMMER R, NESTLE FO, NIEDERER E, LUDWIG E, LAINE E, GRUNDMANN HP, GROB P, BURG G (1999); Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD71 T lymphocyte subsets in Sézary syndrome; Arch Dermatol Res 291: 307 – 311

93.   HESS SCHMID M, DUMMER R, KEMPF W, HILTY N, BURG G (1999): Mycosis fungoides with Mucinosis follicularis in Childhood; Dermatology 198: 284 – 287

94.   FRITZ TM, KLEINHANS M, NESTLE FO, BURG G, DUMMER R (1999); Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with the Sézary syndrome; Br J Dermatol 140: 1144 – 1147

95.   QIN J-Z, DUMMER R, BURG G, DÖBBELING U (1999); Constitutive and Interleukin-7/Interleukin-15 Stimulated DNA Binding of Myc, Jun, and Novel Myc-Like Proteins in Cutaneous T-Cell Lymphoma Cells; Blood 93 (1): 260 – 267

96.   HESS SCHMID M, BIRD P, DUMMER R, KEMPF W, BURG G (1999); Tumor Burden Index as a Prognostic Tool for Cutaneous T-Cell Lymphoma; Arch Dermatol 135: 1204 – 1208

97.   LAETSCH B, HÄFFNER AC, DÖBBELING U, SEIFERT B, LUDWIG E, BURG G (1999); CD4+/CD7- T Cell Frequency and Polymerase Chain Reaction-Based Clonality Assay Correlate with Stage in Cutaneous T Cell Lymphomas; J Invest Dermatol 114: 107-111, 2000

98.   SCHÄRER L, SCHMID MH, MÜLLER B, DUMMER RG, BURG G, KEMPF W (2000); Angiogenesis in cutaneous lymphoproliferative disorders: microvessel density discriminates between cutaneous B-cell lymphomas and B-cell pseudolymphomas; Am J Dermatopathol 2000 22 (2): 140 – 143

99.   HEINZERLING L, DUMMER R, KEMPF W, HESS SCHMID M, BURG G (2000);Intralesional Therapy With Anti-CD20 Monoclonal Antibody Rituximab in Primary Cutaneous B-Cell Lymphoma; Arch Dermatol 136: 374 – 378

100.KAMARASHEV J,DUMMER R, HESS SCHMIDT M, KEMPF W, KURRER M.O, BURG G  (2000); Primary Cutaneous T-Cell-Rich B-Cell Lymphoma and Hodgkin’s Disease in a Patient with Gardner’s Syndrome; Dermatology 201: 362 – 365

101.BÖNI R, XIN H, KAMARASHEV J, UTZINGER E, DUMMER R, KEMPF W, KUTZNER H, BURG G  (2000); Allelic Deletion at 9p21-22 in Primary Cutaneous CD30+ Large Cell Lymphoma; The Journal of Investigative Dermatology 115 / Number 6: 1104 – 1107

102.DUMMER R, DÖBBELING U, GEERTSEN R, WILLERS J, BURG G, PAVLOVIC J  (2001); Interferon resistance of cutaneous T-cell lymphoma-derived clonal Thhelper 2 cells allows selective viral replication; Blood 97 / Number 2: 523 – 527

103.DUMMER R, WILLERS J, DÖBBELING U, BURG G (2001); Aktuelle Aspekte zur Pathogenese von Sézary-Syndrom und Mycosis fungoides; Hautarzt; 52: 189 – 192

104.KAMARASHEV J, BURG G, MINGARI MC, KEMPF W, HOFBAUER G, DUMMER R (2001); Short Communication. Differential Expression of Cytotoxic Molecules and Killer Cell Inhibitory Receptors in CD8+ and CD56+ Cutaneous Lymphomas; Am J Pathol 158 (5): 1593 – 1598

105.WILLERS J, HAEFFNER A, ZEPTER K, STORZ M, UROSEVIC M, BURG G, DUMMER R (2001); The Interferon Inhibiting Cytokine IK is Overexpressed in Cutaneous T Cell Lymphomas Derived Tumor Cells That Fail to Upregulate Major Histocompatibility Complex Class II Upon Interferon-gamma Stimulation; J Invest Dermatol 116: 874 – 879

106.KAMARACHEV J, SCHAERER L, BURG G, HESS SCHMID M, MUELLER B, KEMPF W (2001); Tumor-infiltrating T cells in primary cutaneous B-cell lympho-proliferative disorders; J Cutan Pathol 28: 448 – 452

107.SCHMOOK T, HOFBAUER G, KEMPF W, BURG G, DUMMER R (2001); Granulomatous slack skin. Partielle Remission unter intraläsionärer Gabe von Interferon-alpha und PUVA; Hautarzt 52: 985 – 9

108.BURG G, DUMMER R, HÄFFNER A, KEMPF W, KADIN M (2001); From Inflammation to Neoplasia; Mycosis fngoides evolves from reactive onflammatroy conditions (Lymphoid Infiltrates) transforming into neoplastic plaques and tumors; Arch Dermatol 137: 949 – 952

109.QIN JZ, ZHANG CL, KAMARASHEV J, DUMMER R, BURG G, DÖBBELING Ü (2001); Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells; Blood 98(9): 2778 - 2783

110.UROSEVIC M, WILLERS J, MÜELLER B, KEMPF W, BURG G DUMMER R (2002); HLA-G protein up regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell-T-cell lymphomas and indolent B-cell lymphomas.; Blood. 2002; 99:609-617 by American Society of Hematology

111.ROOS J, HENNIG I, SCHWALLER J, ZBAEREN J, DUMMER R, BURG G, TOBLER A, VIRIGLIO L, CROCE C.M., FREY J.F., BORISCH B (2001); Expression of TCL1 in Hematologic disorders; Pathobiology 2001; 69:59-66

112.HAEFFNER A, TASSIS A, ZEPTER C, STORZ M, TURECI O, BURG G, NESTLE F O (2002); Expression of cancer/testis antigens in cutaneous T-cell lymphomas; Int. J. Cancer 97, 668-670 (2002)

113.KAMARASHEV J, SCHAERER L, BURG G, HESS SCHMID M, MÜELLER B, KEMPF W (2001); Tumor-Infiltrating T cells in primary cutaneous B-cell lympho-proliferative disorders ; J Cutan Pathol 2001, 28: 448-452

114.VONDERHEID E C, BERNENGO M G, BURG G, DUVIC M, HEALD P, LAROCHE L, OLSEN E, PITTELKOW M, RUSSEL-JONES R, TAKIGAWA, M (2002); Update on erythrodermic cutaneous T-cell lymphoma: Report of the International Society for Cutaneous Lymphomas; J Am Acad Dermatol 2002; 46: 95 – 106

115.DUMMER R, KAMARASHEV J, KEMPF W, HAEFFNER A, HESS SCHMID M, BURG G (2002); Junctional CD8+ Cutaneous Lymphomas With Nonaggressive Clinical Behavior; Arch Dermatol. 2002; 138: 199-203

116.KAZAKOV DV, BURG G, DUMMER R, PALMEDO G, MUELLER B, KEMPF W (2002); Primary subcutaneous follicular centre cell lymphoma with involvement of the galea: a case report and short review of the literature; British Journal of Dermatology 2002: 146: 663-666

117.KEMPF W, LEVI E, KAMARASHEV J, KUTZNER H, PFEIFER W, PETROGIANNIS-HALIOTIS T, BURG G, KADIN ME (2002); Fascin expression in CD30-positive cutaneous lymphoproliferative disorders; Journal of Cutaneous Pathology 2002: 29: 295-300

118.KAMARASHEV J, BURG G, KEMPF W, DUMMER R (2002); Prognoseevaluation mittels Immunhistologie; Akt Dermatol 2002; 28: 314-318 ã Georg Thieme Verlag Stuttgart × New York × ISSN 0340-2541

119.CARROZZA P M, KEMPF W, KAZAKOV D V, DUMMER R, BURG G (2002); A case of Sézary's syndrome associated with granulomatous lesions, myelodysplastic syndrome and transformation into CD30-positive large-cell pleomorphic lymphoma; British Journal of Dermatology 2002; 147: 582-586

120.SCHWAB C, WILLERS J, NIEDERER E, LUDWIG E, KUENDIG TH, GROB P, BURG G, DUMMER R (2002); The use of anti-T-cell receptor-Vß antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomas; British Journal of Haematology, 2002, 118; 1019-1026

121.KEMPF W, HAEFFNER A, ZEPTER K, SANDER  C A, FLAIG M J, MUELLER B, PANIZZON R G, HARDMEIER T, ADAMS V, BURG G (2002); Angiolymphoid Hyperplasia With Eosinophilia: Evidence for a T-Cell Lymphoproliferative Origin; Human Pathol 2002; 33: 1023-1030

122.BURG G, KEMPF W, KAZAKOV DV, DUMMER R, FROSCH PJ, LANGE-IONESCU S, NISHIKAWA T, KADIN ME (2003); Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature; British Journal of Dermatology 2003; 148: 580-586

123.KLEINHANS M, TUN-KYI A, GILLIET M, KADIN M, DUMMER R, BURG G, NESTLE FO (2003); Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma; Blood 2003; 101: 1487-1493

124.ROBERTS AA, AMANO M, FELTEN CH, GALVAN M, SULUR G, PINTER-BROWN L, DOEBBELING U, BURG G, SAID J, BAUM L (2003); Galectin-1-Mediated Apoptosis in Mycosis fungoides: The Roles of CD7 and Cell Surface Glycosylation; Mod Pathol 2003; 16(6): 543-551

125.DUMMER R, UROSEVIC M, KEMPF W, KAZAKOV D, BURG G (2003); Imiquimod Induces Complete Clearance of a PUVA-Resistant Plaque in Mycosis fungoides; Dermatology 2003; 207:116-118

126.MAIER T, TUN-KYI A, TASSIS A, JUNGIUS KP, BURG G, DUMMER R, NESTLE FO (2003); Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells; Blood 2003; 102: 2338-2344

127.KAZAKOV D V, MENTZEL T, BURG G, DUMMER R, KEMPF W; Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or meylogenous leukaemia: a coincidence or more?; British Journal of Dermatology 2003: 149; 869-876

128.WILLERS J, DUMMER R, KEMPF W, KÜNDIG T, BURG G, KADIN ME (2003); Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand; Clin Cancer Res 2003: 7; 2744-54

129.ZHANG CL, KAMARASHEV J, QIN JZ, BURG G, DUMMER R, DÖBBELING U (2003); Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells ; J Pathol 2003: 200; 249-54

130.RUEBBEN A, KEMPF W, KADIN ME, ZIMMERMANN DR, BURG G (2004); Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma; Experimental Dermatology 2004: 13: 472-482

131.HASSEL J., MEIER R., JOLLER-JEMELKA H., BURG G., DUMMER R. (2004); Serological Immunomarkers in Cutaneous T Cell Lymphoma; Dermatology 2004; 209: 296-300

132.GREISSER J., DOEBBELING U., ROOS M., MUELLER B., SCHMID M., BURG G., KADIN ME., KEMPF W. (2005); Apoptosis in CD30-positive lymphoproliferative disorders of the skin; Experimental Dermatology 2005: 14: 380-385

133.WILLEMZE R, JAFFE E. S, BURG G, CERRONI L, BERTI E, SWERDLOW S H, RALFKIAER E, CHIMENTI S, DIAZ-PEREZ J,  L, DUNCAN L M, GRANGE F, HARRIS N L, KEMPF W, KERL H, KURRER M, KNOBLER R, PIMPINELLI N, SANDER C, SANTUCCI M, STERRY W, VERMEER; M H, WECHSLER J, WHITTAKER S, MEIJER C J  (2005).;"WHO-EORTC classification for cutaneous lymphomas." ; Blood 105(10): 3768-85

134.UROSEVIC M, CONRAD C, KAMARACHEV J, ASAGOE K, COZZIO A, BURG G, DUMMER R (2005); CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype; Journal of Human Pathology (2005) 36, 1020 – 1024

135.BURG G, KEMPF W, COZZIO A, FEIT J, WILLEMZE R, JAFFE E.S, DUMMER R, BERTI E, CERRONI L, CHIMENTI S, DIAZ-PEREZ J.L, GRANGE F, HARRIS N.L,KAZAKOV D.V, KERL H, KURER M, KNOBLER R, MEIJER CH. J.L.M, PIMPINELLI N, RALFKIAER E, RUSSEL-JONES R, SANDER CH, SANTUCCI M, STERRY W, SWERDLOW ST.H, VERMEER M.H., WECHSLER J, WHITTAKER S (2005); WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects; Journal of Cutaneous Pathology 2005;32:647-674

136.DUMMER R, UROSEVIC M,COZZIO A, ASAGOE K, DÖBBELING U, BURG G (2006); Perspektiven der Forschung bei kutanen Lymphomen; Perspectives concerning research in cutaneous lymphomas; Journal German Dermatologic Society (JDDG) 2006; 4; 492-495

137.COZZIO A, KEMPF W, SCHMID-MEYER R, GILLIET M, MICHAELIS S, SCHA¨ RER L, BURG G,  DUMMER R; Intra-lesional low-dose interferon a 2a therapy for primary cutaneous marginal zone B-cell lymphoma

138.GREISSER J, PALMEDO G, SANDER C, KUTZNER H, KAZAKOV D, ROOS M, BURG G, KEMPF W (2006); Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30+ lymphoproliferative disorders; J Cutan Pathol

139.BURG G (1976) ; Fortschritte in der Diagnostik kutaner Lymphome. Enzymzytochemische und immunzytologische Untersuchungen; Fortschr Med 94: 1089-1098;

140. BRAUN-FALCO O, BURG G, WOLFF HH (1976) ; Kutane Lymphome und Pseudolymphome. Immunzytologische, enzymzytochemische und elektronenmikroskopische Untersuchungen; Therap Umschau 33: 543-550

141.BRAUN-FALCO O, BURG G (1976) ; Adelantos en la Diferenciacion y Clasificacion del Linfoma cutaneo ; Dermatologia Revista Mexicana, XX, 3: 265-272

142.BURG G (1977) ; Moderne Aspekte in der Diagnostik und Klassifikation kutaner Lymphome; Hautarzt 28, Suppl. II: 280-282

143.BURG G, BRAUN-FALCO O (1977) ; Morphological and functional differentiation and classification of cutaneous lymphomas; Bull du Cancer 64: 225-240

144. BURG G, BRAUN-FALCO O, SCHMOECKEL CH, WOLFF HH (1977) ;Fortschritte in der Diagnostik kutaner Lymphome;Hautarzt 8, Suppl. II: 346-348;

145.BURG G, BRAUN-FALCO O (1978) ; Cutaneous Non-Hodgkin Lymphoma: Re-evaluation of histology using enzymecytochemical and immunologic studies; Int J Dermatol 17: 496-505

146.BURG G, BRAUN-FALCO O (1978); Methoden zur Klassifikation der Hautlymphome; Hautarzt 29, Suppl. III: 5-13

147.BURG G, BRAUN-FALCO O, SCHMOECKEL C (1988); Kutane T-Zell-Lymphome; Fortschr Med 96: 199-20

148.BRAUN-FALCO O, BURG G, SCHMOECKEL C (1978) ; Klassifikation von malignen Hautlymphomen; Hautarzt 29, Suppl. 111: 37-45

149.BURG G (1979) ; Retikulosen und Lymphome der Haut aus heutiger Sicht; Hautarzt 30: 167-168

150.BRAUN-FALCO O, SCHMOECKEL C, BURG G, RYCKMANNS F(1979); Pagetoid reticulosis; Acta Dermatovener 59, Suppl 85: 1-21

151.BRAUN-FALCO O, BURG G, HOFFMANN-FEZER G, FATEH-MOGHADAM A,HERTERICH J (1980); Die "Retikulosen" der Haut - eine heterogene Gruppe von Erkrankungen; Acta Histochem Suppl XXI: 57-69

152.BRAUN-FALCO O, BURG G, SCHMOECKEL C (1981) ; Recent advances in the understanding of cutaneous lymphoma; Clin Exp Dermatol 6: 89-109

153.BURG G, SCHMOECKEL C, BRAUN-FALCO O (1981) ; Möglichkeiten zur Abgrenzung von Pseudolymphomen und malignen B-Zell-Lymphomen der Haut; Hautarzt Suppl. V: 210-217

154.BRAUN-FALCO O, NIKOLOWSKI J, BURG G, SCHMOECKEL C (1983) ; Lymphomatoide Papulose; Hautarzt 34: 59-65

155.BRAUN-FALCO O, BURG G (1983) ; Maligne Lymphome der Haut; Internist 24: 306-320

156.BURG G, KERL H, SCHMOECKEL CH (1984) ; Differentiation between malignant B-cell lymphomas and pseudolymphomas of the skin; J Dermatol Surg Oncol 10:271-275

157.BURG G, KERL H, PRZYBILLA B, BRAUN-FALCO O (1984) ; Some statistical data, diagnosis, and staging of cutaneous B-cell lymphomas;J Dermatol Surg Oncol 10:256-262

158.BURG G, KAUDEWITZ P, KLEPZIG K, PRZYBILLA B, BRAUN-FALCO O (1985); Cutaneous B-cell lymphoma; Dermatologic Clinics 3:689-704

159.KAUDEWITZ P, BURG G, SMOLLE J (1986) ; Immunologische Phänotypisierung kutaner Lymphome; Hautarzt 37:647-655

160.SMOLLE J, KAUDEWITZ P, ABERER E, TORNE R, BURG G, KERL H (1987); Immunhistochemische Klassifikation von kutanen Lymphomen und Pseudolymphomen; Hautarzt 38: 461-466

161.BURG G (1988) ; Häufigkeit und Klassifikation der Hautlymphome; Hautarzt 39, S VIII: 276-277

162.BURG G, KERL H (1991) ; Cutaneous Lymphomas and Pseudolymphomas – Introduction; Sem Diagn Pathol 8:53-54

163.KAUDEWITZ P, BURG G (1991) : Lymphomatoid Papulosis and Ki-1 (CD30)-Positive Cutaneous Large Cell Lymphomas; Sem Diagn pathol 8:117-124

164.KERL H, CERRONI L, BURG G (1992) ; The Morphologic Spectrum of T-Cell Lymphomas of the Skin: A Proposal for a New Classifica­tion; Sem Diagn Pathol 8:55-61

165.BURG G, DOMMANN S, DUMMER R (1993); Maligne Lymphome der Haut; Therapeutische Umschau 50, 12:828-834

166.BURG G, DUMMER R, KERL H (1994); Classification of cutaneous lymphomas; Dermatologic Clinics 12;2:213-217

167. BURG G, DUMMER R, DOMMANN ST, NESTLE F, NICKOLOFF B (1995); Pathology of cutaneous T-cell lymphoma; Hematology/Oncology Clinics of North America 9(5): 961 – 995

168. DUMMER R, HÄFFNER AC, HESS M, BURG G (1996); Rational Approach to the Therapy of Cutaneous T-Cell Lymphomas; Onkologie 1996; 19: 226 – 230

169.NESTLE FO, HÄFFNER AC, HESS SCHMID M, DUMMER R, BURG G (1997); Moderne Therapiekonzepte bei kutanen T-Zell-Lymphomen; Schweiz Med Wochenschr 1997; 127: 311 – 320

170.BURG G (1997); Ungewöhnliche Varianten kutaner Lymphome; Unusual variants of cutaneous lymphomas; H+G 4 (72); 253 – 256

171.JAFFE ES, BURG G (1997); Report of the Symposium on Cutaneous Lymphomas: Sixth International Conference on Malignant Lymphoma; Annals of Oncology 8 (Suppl. 1): 83 – 84

172.BURG G (1999); Challenges in Cutaneous Lymphomas: A Morphologist's Perspective (Review articlein "Cutaneous Lymphomas XVIII; Masahiro Takigawa (editor); Japanese Society for Cutaneous Lymphomas, Abstraktband 1999.5; p 2 – 20

173.ROGALSKI C, DUMMER R, BURG G (1999); Immunomodulators in the treatment of cutaneous lymphoma; Journal of the European Academy of Dermatology and Venerology 13: 83 – 90

174.KAMARASHEV J, KEMPF W, DUMMER R, MÜLLER B, BURG G (2000); Cutaneous lymphomas; G Ital Dermatol Venereol 135: 29 – 48

175.BURG G (2000); Cutaneous Lymphomas; Medical Dermatology Part I; Current Problems in Dermatology; 12 (1): 25 – 29

176.DUMMER R, WILLERS J, KAMARASHEV J, UROSEVIC M, DÖBBELING Ü, BURG G; Pathogenesis of Cutaneous Lymphomas; Seminars in Cutaneous Medicine and Surgery 109 (2): 78 – 86

177.BURG G (2000); Cutaneous Lymphomas: Classification and Staging; AIDA (Sonderheft) VIII; 1: 39-44

178.DUMMER R, HESS-SCHMID M, BURG G (2000); Cutaneous T-Cell Lymphomas: Prognosis and Quality-of-Life Issues; Clinical Lymphoma suppl. Vol. 1: 21 – 25

179.KEMPF W, DUMMER R, BURG G (2001); Klinische und therapeutische Besonderheiten kutaner Lymphome; Deutsches Ärzteblatt 98; 11: 697 – 703

180.KNOBLER R, BURG G, WHITTAKER S, BAILA L (2002); EORTC Cutaneous Lymphoma Task Force; European Journal of Cancer 38 (2002) S60-S64

181.DUMMER R, UROSEVIC M, DÖBBELING U, BURG G (2003); Immunobiology of cutaneous T-cell lymphomas; haematologica 2003, Volume 88; supplement No. 5 – April 2003

182DUMMER R, KEMPF W, HESS SCHMID M, HAEFFNER A, BURG G (2003); Therapy of Cutaneous DRAGIEVA G, KEMPF W, BURG G, HESS M, SCHÄRER L, KETTELHACK N, PRINZ BM, DUMMER R, HAFNER J (2003): Hautveränderungen bei organtransplantierten, immunsupprimierten Patienten. Haut 2003; XIV: 172Lymphoma – Current Practice and Future Developments; Onkologie 2003; 26:366-372

183DUMMER R, BEYELER M, HESS SCHMID M, KEMPF W, BURG G (2003); Diagnostik und Therapie kutaner Lymphome; Schweiz Med Forum 2003; 47: 1136-1143

184KEMPF W, KETTELHACK N, DUVIC M, BURG G (2003); Topical and systemic retinoid therapy for cutaneous T-cell lymphoma; Hematol Oncol Clin N Am 17 (2003): 1405-1419

185.KAZAKOV DV, BURG G, KEMPF W (2004)¸Clinicopathological spectrum of mycosis fungoides; JEADV 2004; 18, 397-415

186.BEYELER M, BURG G, DUMMER R (2004); Kutane Lymphome; Der Hautarzt 2004; 55:1005-1017

187.BURG G, KEMPF W, COZZIO A, DÖBBELING U,FEIT J, GOLLING P,MICHAELIS S, SCHÄRER L, NESTLE F, DUMMER R (2006); Kutane maligne Lymphome: Update 2006 zu ausgewählten Aspekten; JDDG 2006; 4: 914-934

188.BURG G, KEMPF W, DUMMER R (2007); Cutaneous Lymphomas : Current and future concepts; J Egypt wom Derm Soc 4(1), 1-23

189.KAZAKOV DV, BURG G, KEMPF W (2004): Clinicopathological spectrum of mycosis fungoides. JEADV 2004; 18, 397-415

190.BEYELER M, BURG G, DUMMER R (2004): Kutane Lymphome. Der Hautarzt 2004; 55:1005-1017

191.BURG G, KEMPF W, COZZIO A, DÖBBELING U,FEIT J, GOLLING P,MICHAELIS S, SCHÄRER L, NESTLE F, DUMMER R (2006): Kutane maligne Lymphome: Update 2006 zu ausgewählten Aspekten. JDDG 2006; 4: 914-934

192.BURG G, KEMPF W, DUMMER R (2007): Cutaneous Lymphomas : Current and future concepts. J Egypt wom Derm Soc 4(1), 1-23

193.BURG G, RODT H, GROSSE-WILDE H, NETZEL B, FATEH-MOGHADAM A, BRAUN-FALCO O (1977): Enzymzytochemical and immuncytological studies as a basis for the reevaluation of the histolo­gy of cutaneous B-cell and T-cell lymphomas. In: S.S. Thierfelder, H. Rodt, E. Thiel (Hrsg.): Haematology and Blood Transfusion, Vol. 20:Immunological Diagnosis of Leukemias and Lymphomas, S. 179-187. Springer, Berlin-Heidelberg-New York

194.BURG G (1979): Moderne Diagnostik and stadiengerechte Therapie kutaner Lymphome. In: O. Braun-Falco und H.H. Wolff (Hrsg.): Fortschritte der praktischen Dermatologie und Venerologie, Vol. 9, S. 215-227. Springer, Berlin-Heidelberg-New York

195.BURG G (1981): Malignant histiocytic disorders of the skin. In: F. Schmalzl, D. Huhn, H.E. Schaefer (Hrsg.): Haematology and Blood Transfusion Vol 27: 221-224. Disorders of the Monocyte Macrophage System. Springer-Verlag, Berlin-Heidelberg-New York

196.KUMMERMEHR J, BURG G (1982): Autoradiographic pattern of cell proliferation in cutaneous malignant lymphoma. In: M. Goos, E. Christophers (Hrsg.): Lymphoproliferative Diseases of the skin, S. 71-78. Springer Verlag, Berlin-Heidelberg-New York

197.BURG G, BRAUN-FALCO O, HOFFMANN-FEZER G, SCHMOECKEL C (1982): Differentiation between pseudolymphomas and malignant B cell lymphomas of the skin. In: M. Goos and E. Christophers (Hrsg.): Lymphoproliferative Diseases of the skin, S. 101-107. Springer Verlag, Berlin-Heidelberg-New York

198.NIKOLOWSKI J, BURG G, SCHMOECKEL C, BRAUN-FALCO O, HOFFMANN-FEZER G (1982): Lymphomatoid papulosis: A cutaneous T cell pseudo-lymphoma?. In: M. Goos, E. Christophers (Hrsg.): Lymphoproliferative Diseases of the Skin, S. 163-167. Springer Verlag, Berlin-Heidelberg-New York

199.GUGGENBERGER K, BURG G, SCHMOECKEL C, DETMAR U (1982) : Follow-ups in cutaneous immunocytomas. In: M. Goos, E. Christophers (Hrsg.): Lymphoproliferative Diseases of the Skin, S. 192-196. Springer Verlag, Berlin-Heidelberg-New York

200.SCHMOECKEL C, BURG G, HOFFMANN-FEZER G, WOLFF HH, BRAUN-FALCO O (1982): Pagetoid reticulosis - a rare entity?. In: M. Goos, E. Christophers (Hrsg.): Lymphoproliferative Diseases of the Skin,S. 217-221. Springer Verlag, Berlin-Heidelberg-New York

201.BRAUN-FALCO O, KRESBACH H, BURG G, KERL H (1982): German-Austrian cutaneous lymphoma cooperative study group. In: M. Goos, E. Christophers (Hrsg.): Lymphoproliferative Diseases of the Skin, S. 256-259. Springer Verlag, Berlin-Heidelberg-New York

202.SCHMOECKEL C, BURG G, HOFFMANN-FEZER G, WEITZ H, BRAUN-FALCO O (1982): Cutaneous immunoblastic T-cell lymphoma. In: XVI Congressus Internationalis Dermatologiea1982 Tokyo, Case Presenta­tions S. 71-72. University Press of Tokyo

203.KAUDEWITZ P, KIND P, BURG G, RIEBER P, BERGER C, EDELSON R, BRAUN-FALCO O (1984): Longitudinal study of surface antigen pattern in cutaneous T-cell lymphomas. In: DM MacDonald (Hrg.): Immunodermatology, S. 123-124. Butterworth London-Boston-Durban-Sydney-Toronto-Washington

204.BURG G (1984): Lymphome: Diagnostik und Klassifikation. In: J. Petres, J. Kunze, RPA Müller (Hrsg.): Onkologie der Haut, S. 179-189. Grosse Verlag, Berlin

205.BURG G (1984): Kooperative Studiengruppe "Kutane Lymphome".  Geplante Therapie-Konzepte. In: J. Petres, J. Kunze, RPA Müller (Hrsg.): Onkologie der Haut, S. 240-243. Grosse Verlag, Berlin

206.BURG G (1987): Cutaneous Lymphomas. In: C.E.Orfanos, R. Stadler, H. Gollnick (Hrgs.): Dermatology in Five Continents, S. 188-193. Springer, Berlin-Heidelberg-New York

207.BURG G, KAUDEWITZ P (1990): Where we are today in the Diagnosis of Cutaneous Lymphoma?. In: van Vloten WA et al. (eds): Curr Probl Dermatol. Cutaneous Lymphoma, Vol 19: 90-104. Karger, Basel

208.KAUDEWITZ P, BURG G, STEIN N (1990): Ki-1 (CD30) positive cutaneous anaplastic large cell lymphomas. In: van Vloten WA et al (eds): Curr Probl Dermatol. Cutaneous Lymphomas, Vol 19: 150-156. Curr Probl Dermatol, Karger, Basel

209.BURG G, ZIFFER S, LANZ U (1990): Light and electron microscopy findings in lymphomatoid papulosis.. In: Muller SA (ed): Parapsoriasis. S. 78-81. Mayo Foundation Rochester

210.WEIDENHILLER M, ACKERMANN S, DUMMER R, BURG G (1992) Zytokin- und Zytokin-rezeptor-Expression in kutanen Lymphomen. In: G Burg, AA Hartmann, B Konz (Hrsg.): Onkologische Dermatologie. S 41-48. Springer Verlag, Berlin-Heidelberg-New York

211.BURG G, ZIFFER S, LANZ U (1990): Light and electron microscopy findings in lymphomatoid papulosis.. In: Muller SA (ed): Parapsoriasis. S. 78-81,. Mayo Foundation Rochester

212.KOHL O, DUMMER R, GILLESSEN J, BURG G (1992): Interleukin-4 (IL-4) und kutane T-Zell-Lymphome (CTCL). In: G Burg, AA Hartmann, B Konz (Hrsg.): Onkologische Dermatologie. S 75-81. Springer Verlag, Berlin-Heidelberg-New York

213.BURG G, HEFNER H, RÖGER J, VOGT T, DUMMER R (1992). Topische Behandlung kutaner T-Zell-Lymphome mit Carmustin (BCNU). In: G Burg, AA Hartmann, B Konz (Hrsg.): Onkologische Dermatologie. S 171-173. Springer Verlag, Berlin-Heidelberg-New York

214.BURG G, DUMMER R, SCHMID MH, FELLER A (1993): B-cell lymphomas and B-cell pseudolymphomas. In: W.H.C. Burgdorf, S.I. Katz (eds.): Dermatology, Progress & Perspectives. The Proceedings of the 18th World Congress of Dermatology. The Parthenon Publisher Group, New York, Casterton, London 1993, p 618-621

215.BURG G (1992): Cutaneous B Cell Lymphoma, Multiple Myeloma, And Myelomonocytic Leukemia. In: Moschella and Hurley (eds.), 3^rd ed. Dermatology, Chapter 69: 1829-1844. W. B. Saunders Company, Philadelphia, London, Toronto, Montreal, Sydney, Tokyo

216.BURG G, BERTI E, EVERETT MA (1993): Chair’s summary: Immunophenotyping of cutaneous lymphomas. In: W.H.C. Burgdorf, S.I. Katz (eds.): Dermatology, Progress & Perspectives, S. 1142-1145. The Proceedings of the 18th World Congress of Dermatology. The Parthenon Publisher Group, New York, Casterton, London

217.BURG G (1993): Histiozytosen. In: O. Braun-Falco, G. Plewig, M. Meurer (Hrsg.): Fortschritte der praktischen Dermatologie und Venerologie, S. 3-9. Springer-Verlag Berlin, Heidelberg, New York, London,

218.DUMMER R, DOMMANN SNW, HASSAM SH, BÖNI R, DÖBBELING U, NESTLE FO, BURG G (1994). : Diagnostik und Pathogenesen kutaner Lymphome. . In: E Macher, G. Kolde, E.B. Bröcker (Hrsg.): Jahrbuch (1994/95) der Dermatologie - Tumoren und Haut - . Biermann Verlag FRG, p 151-164Paris

219.BURG G (1994): Dermatologia ed Ematologia / Dermatologia e i suoi Limitrofi. 31° Congresso Nazionale Associazione Dermatologi Ospedalieri Italiani. Merano, 28.-31. Ottobre 1992(Kongressbuch: Erschienen VII n. 2 Maggio 1994, S. 73-77)

220.BURG G, HÄFFNER A, BÖNI R, DOMMANN S, DUMMER R (1995): New Perspectives in Experimental and Clinical Research for Cutaneous T Cell Lymphomas. III. Cutaneous Lymphoma. In: Recent Results in Cancer Research, Vol. 139: 225-237. Springer-Verlag Berlin-Heidelberg

221.BURG G, DUMMER R, DOMMANN ST, BÖNI R, DÖBBELING U, NESTLE F (1995): Maligne Lymphome der Haut. Klinische Besonderheiten und aktuelle Therapiekonzepte. In: Diehl V, Schlag R, Thoel E (Hrsg.): Morbus Hodgkin und Non-Hodgkin-Lymphome, S. 126 – 150. Karger Verlag Basel

222.DUMMER R, BURG G (1995): Pathogenetisch orientierte Perspektiven einer zukünftigen Behandlung kutaner Lymphome. In: Tebbe B, Goerdt S, Orfanos CE (Hrsg.): Dermatologie. Heutiger Stand. S. 235 – 237. Ergebnisse und Berichte der 38. Tagung der Deutschen Dermatologischen Gesellschaft in Berlin vom 29. April bis 3. Mai 1995. Georg Thieme Verlag Stuttgart - New York

223.BURG G, DUMMER R, DOMMANN ST (1996): Other Cutaneous Lymphomas: B-Cell Lymphoma, Non-Mycosis Fungoides T-Cell Lymphoma, and Adult T-Cell Lymphoma/Leukemia. In: Kenneth A. Arndt  et al. (eds.): Cutaneous Medicine And Surgery: An Integrated Program in Dermatology. Vol. 2, Chapter 159: 1660-1669. W.B. Saunders Company, Philadelphia, London, Toronto, Montreal, Sydney, Tokyo

224.KALINKE D.U., DUMMER R, BURG G (1996): Management of cutaneous T-cell lymphoma. In: Mark V. Dahl (editor): Current Opinion in Dermatology, Vol. 3: S.71-76. Pearon G. Lang (editor): Neoplasms. . Rapid Science Publishers, Philadelphia, PA

225.BURG G, DOMMANN S, PÖTTER R, SCHLAPPACK O, DUMMER R (1997): Kutane Non-Hodgkin-Lymphome. In: H.-J. Schmoll, K. Höffken, K. Possinger (Hrsg.): Kompendium Internistische Onkologie. 2. Auflage, Teil 2. S 293 - 308 . Springer-Verlag Berlin, Heidelberg, New York

226.POTOCZNA N, MÜLLER B, BURG G, DUMMER R (1996): Immunhistochemischer Klonalitätsnachweis in kutanen T-Zell-Lymphomen mittels monoklonaler Antikörper gegen die variable Region des T-Zell-Rezeptors. . In: R. Dummer, R. Panizzon, G. Burg (Hrsg.): Fortschritte der operativen und onkologischen Dermatologie, Band 11, S. 203 – 207. Operative und konservative Dermatoonkologie im interdisziplinären Grenzbereich. Blackwell Wissenschaftsverlag Berlin-Wien 1996

227.MEYER JCH, HASSAM S, DUMMER R, MULETTA S, DÖBBELING U, DOMMANN SNW (1996): Konalitätsnachweis bei Verdacht auf kutanes T-Zell-Lymphom: Vertgleich von PCR-DGGE des T-Zell-Rezeptor-Gamma-Gens mit der Southern-Blot-Analyse (SBA) des T-Zell-Rezeptor-Beta-Gens. . In: R. Dummer, R. Panizzon, G. Burg (Hrsg.): Fortschritte der operativen und onkologischen Dermatologie, Band 11, S. 208-211. Operative und konservative Dermatoonkologie im interdisziplinären Grenzbereich. Blackwell Wissenschaftsverlag Berlin-Wien 1996

228.BURG G, DUMMER R (1998): Leitlinien: kutane Lymphome. In: C. Garbe, G. Rassner (Hrsg.): Dermatologie. Leitlinien und Qualitätssicherung für Diagnostik und Therapie. Berichte von der 39. Tagung der Deutschen Dermatologischen Gesellschaft, S. 363 – 368. Springer Verlag Berlin Heidelberg New York 1998

229.DUMMER R, DÖBBELING U, GEERTSEN R, WILLERS J, BURG G (1999): Pathogenese kutaner T-Zell-Lymphome, S. 455 – 456. In: A. Plettenberg, W.N. Meigel, I. Moll (Hrsg.): Dermatologie an der Schwelle zum neuen Jahrtausend . Aktueller Stand von Klinik und Forschung. Springer Verlag Berlin, Heidelberg, New York

230.BURG G (1999) : Pseudolymphomas: B-cell pseudolymphoma, T-cell pseudolymphoma. . In:  G. Burg (Hrsg): Atlas of Cancer of the Skin, S. 109 - 112. . Churchill Livingstone, New York

231.BURG G (1999): Histiocytic Disorders.. In:  G. Burg (Hrsg): Atlas of Cancer of the Skin, S. 130 – 145. Churchill Livingstone, New York

232.BURG G, KEMPF W, DUMMER R (2002): Kutane Lymphome, P 33 –51. In: B. Konz, G. Plewig (Hrsg): Fortschritte der Dermatologie. Ein Rückblick auf 50 Jahre anlässlich des 80. Geburtstages von Herrn Professor Dr. Dr. h.c. mult. Otto Braun-Falco. Steinkopff Verlag Darmstadt

233.KAZAKOV DV, BURG G, DUMMER R, KEMPF W (2002): Cutaneous Lymphomas and Pseudolymphomas: Newly Described Entities. Recent Results in Cancer Research, Vol. 160. Springer-Verlag Berlin Heidelberg 2002

234.BURG G, KEMPF W, HAEFFNER A, DOEBBELING U, NESTLE F O, BOENI R, KADIN M, DUMMER R (2002) : From Inflammation to Neoplasia: New Concepts in the Pathogenesis of Cutaneous Lymphomas. (Buch) Cancers of the Skin / Proceedings of the 8^th World Congress (S 271 - 280)

235.BURG G, KEMPF W, MICHAELIS S, SCHÄRER L, DUMMER R (2005): T- und B-Zell-Neoplasien der Haut. In: G. Plewig, P. Kaudewitz, C.A. Sander: Fortschritte der praktischen Dermatologie und Venerologie vol. 19. Springer-Verlag Berlin Heidelberg 2005

236.KEMPF W, BURG G (2005): Maligne Lymphome der Haut. In: O. Braun-Falco, G. Plewig, H. Wolff, W. Burgdorf, M. Landthaler: Dermatologie und Venerologie 5. Auflage. Springer Medizin Verlag Heidelberg 2005

237.DUMMER R, UROSEVIC M, COZZIO A, BURG G (2005): Targeting the cytokine dysbalance for the immunotherapy of cutaneous T-cell lymphomas . Eurocancer 2005. John Libbey Eurotext, Paris 2005, pp. 159-160

238.BURG G, KEMPF W, SMOLLER B, RALFKIAER E, KAZAKOV D.V, SANDER C, FEIT J, LEBOIT PH (2006): Mycosis fungoides. World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 169-174; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

239.RUSSEL-JONES R, BERNENGO M, BURG G, LAROCHE L, MICHAELIS S, RALFKIAER E, VONDERHEID E, WHITTAKER S (2006): Sézary syndrome. World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 175-177; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

240.KEMPF W, KAZAKOV D.V, MICHAELIS S, BURG G, LEBOIT P (2006): Granulomatous slack skin . World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 178; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

241.KEMPF W, WILLEMZE R, JAFFE E.S, BURG G, KADIN M.E (2006): CD30+ T-cell lymphoproliferative disorders . World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 179-181; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

242.JAFFE E.S, BURG G (2005): Subcutaneous panniculitis-like T-cell lymphoma. World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 182-183; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

243.RALFKIAER E, WILLEMZE, MEIJER C.J.L.M, DUMMER R, JAFFE E.S, SWERDLOW S.H, BERTI E, KEMPF W, BURG G, CERRONI L, TORO J.R (2006): Primary cutaneous peripheral T-cell lymphoma, unspecified . World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 184-188; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

244.KEMPF W, RALFKIAER E, DUNCAN L, BURG G, WILLEMZE R, SWERDLOW S.H, JAFFE E.S (2006): Cutaneous marginal zone B-cell lymphoma . World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 194-195; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

245.PIMPINELLI N, BERTI E, BURG G, DUNCAN L, HARRIS N.L, JAFFE E.S, KERL H, KURRER M, KEMPF W, MEIJER C.J.L.M, SANTUCCI M, SWERDLOW S.H, WILLEMZE R (2006): Cutaneous follicle centre lymphoma. World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 196-197; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

246.BURG G, JAFFE E.S, WILLEMZE R, DOMMANN-SCHERRER C, SWERDLOW S.H, KEMPF W, KURRER M, KUTZNER H, WECHSLER J, HARRIS N.L (2005): Cutaneous diffuse large B-cell lymphoma. World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 198-199; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

247.SANDER C.A, JAFFE E.S, FLAIG M.J, DUMMER R, KAZAKOV D.V, KEMPF W, BURG G (2006): Blastic NK-cell lymphoma. World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 208-209; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

248.SANDER C.A, JAFFE E.S, BURG G (2006): Precursor T-lymphoblastic leukaemia / lymphoma and precursor B-lymphoblastic leukaemia / lymphoma. World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 210; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

249.BURG G, KEMPF W, SANDER C.A, WOOD G, SCHMID U, COGLIATTI S (2006): Lymphoid infiltrates of the skin mimicking lymphoma (cutaneous pseudolymphoma) . World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 212-214; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

250.BURG G, SANTUCCI M, SMOLLER B, GUITART J, EVERETT M, KEMPF W (2006): Parapsoriasis. World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 215-216; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

251.ZELGER B, RAPINI R.P, BURGDORF W, BURG G (2006): Langerhans cell histiocytosis . World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 217-219; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

252.KEMPF W, BURG G (2008): Kutane lympoproliferative und hämatopoetische Erkrankungen. In: A. Cardesa, Th Mentzel, P. Rudolph, P.J. Slootweg (Hrsg.). Pathologie. Springer Berlin, Heidelberg, 2009 . Seite 979-1002